AGTR1 and neoplasm: AngII was reported to facilitate tumour migration, proliferation, angiogenesis and metastasis by activating AngII type 1 receptor (AT1R) [28–30], while the activation of AngII type 2 receptor (AT2R) promotes tumour proliferation and angiogenesis in lung cancer [31, 32].